Peregrine Asset Advisers, Inc. Bristol Myers Squibb CO Transaction History
Peregrine Asset Advisers, Inc.
- $244 Million
- Q2 2024
A detailed history of Peregrine Asset Advisers, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Peregrine Asset Advisers, Inc. holds 22,964 shares of BMY stock, worth $1.22 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
22,964
Previous 15,654
46.7%
Holding current value
$1.22 Million
Previous $848,000
12.38%
% of portfolio
0.39%
Previous 0.36%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...